The Cool Chain Association (CCA) is to highlight the need for collaborative solutions in the pharmaceutical supply chain, with a focus on innovation and data sharing, at its forthcoming 7th Pharma and Biosciences Conference.
The conference is to take place in Paris, France, in September.
Drones, automation and digitisation will also feature as important themes at the two-day conference, which brings together decision-makers from across the global pharma supply chain.
“It takes 10,000 miles to reach the final one, and all too often that is when the cargo is compromised,” noted Stavros Evangelakakis, head of global healthcare at freighter operator Cargolux as well as CCA chairman.
“Without jeopardising what has been done prior to the shipment arriving at the final leg of its journey, we need to better investigate ways to collaborate and embrace innovative ideas to make sure we are working with our stakeholders to be part of the solution.”
Evangelakakis continued: “This is important, not only to ensure we drive the high-quality cost-effective services they deserve, but also because we will be helping ensure that critical pharma supplies are successfully delivered to the end destination – to the patients who need it.”
CCA expects to explore how stakeholders in the pharma supply chain can work together to provide the infrastructure needed to ensure a successful end-to-end cool chain delivery.
“The conference will be part of an ongoing push to bring all stakeholders together and find new and better ways of working together,” said CCA secretary general Edwin Kalischnig.
“Our vision is to contribute to making the world a better place by helping to improve the cool chain.”
CCA is a non-profit organisation that aims to improve the quality, efficiency and value of the temperature-sensitive supply chain, in order to help reduce and prevent loss in the chain.
